Cargando…

Bacteremia in hemodialysis patients

Infection is a common complication and is the second leading cause of death in hemodialysis patients. The risk of bacteremia in hemodialysis patients is 26-fold higher than in the general population, and 1/2-3/4 of the causative organisms of bacteremia in hemodialysis patients are Gram-positive bact...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Masashi, Satoh, Nobuhiko, Nakamura, Motonobu, Horita, Shoko, Seki, George, Moriya, Kyoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099594/
https://www.ncbi.nlm.nih.gov/pubmed/27872830
http://dx.doi.org/10.5527/wjn.v5.i6.489
_version_ 1782465992485502976
author Suzuki, Masashi
Satoh, Nobuhiko
Nakamura, Motonobu
Horita, Shoko
Seki, George
Moriya, Kyoji
author_facet Suzuki, Masashi
Satoh, Nobuhiko
Nakamura, Motonobu
Horita, Shoko
Seki, George
Moriya, Kyoji
author_sort Suzuki, Masashi
collection PubMed
description Infection is a common complication and is the second leading cause of death in hemodialysis patients. The risk of bacteremia in hemodialysis patients is 26-fold higher than in the general population, and 1/2-3/4 of the causative organisms of bacteremia in hemodialysis patients are Gram-positive bacteria. The ratio of resistant bacteria in hemodialysis patients compared to the general population is unclear. Several reports have indicated that hemodialysis patients have a higher risk of methicillin-resistant Staphylococcus aureus infection. The most common site of infection causing bacteremia is internal prostheses; the use of a hemodialysis catheter is the most important risk factor for bacteremia. Although antibiotic lock of hemodialysis catheters and topical antibiotic ointment can reduce catheter-related blood stream infection (CRBSI), their use should be limited to necessary cases because of the emergence of resistant organisms. Systemic antibiotic administration and catheter removal is recommended for treating CRBSI, although a study indicated the advantages of antibiotic lock and guidewire exchange of catheters over systemic antibiotic therapy. An infection control bundle recommended by the Center for Disease Control and Prevention succeeded in reducing bacteremia in hemodialysis patients with either a catheter or arteriovenous fistula. Appropriate infection control can reduce bacteremia in hemodialysis patients.
format Online
Article
Text
id pubmed-5099594
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-50995942016-11-21 Bacteremia in hemodialysis patients Suzuki, Masashi Satoh, Nobuhiko Nakamura, Motonobu Horita, Shoko Seki, George Moriya, Kyoji World J Nephrol Minireviews Infection is a common complication and is the second leading cause of death in hemodialysis patients. The risk of bacteremia in hemodialysis patients is 26-fold higher than in the general population, and 1/2-3/4 of the causative organisms of bacteremia in hemodialysis patients are Gram-positive bacteria. The ratio of resistant bacteria in hemodialysis patients compared to the general population is unclear. Several reports have indicated that hemodialysis patients have a higher risk of methicillin-resistant Staphylococcus aureus infection. The most common site of infection causing bacteremia is internal prostheses; the use of a hemodialysis catheter is the most important risk factor for bacteremia. Although antibiotic lock of hemodialysis catheters and topical antibiotic ointment can reduce catheter-related blood stream infection (CRBSI), their use should be limited to necessary cases because of the emergence of resistant organisms. Systemic antibiotic administration and catheter removal is recommended for treating CRBSI, although a study indicated the advantages of antibiotic lock and guidewire exchange of catheters over systemic antibiotic therapy. An infection control bundle recommended by the Center for Disease Control and Prevention succeeded in reducing bacteremia in hemodialysis patients with either a catheter or arteriovenous fistula. Appropriate infection control can reduce bacteremia in hemodialysis patients. Baishideng Publishing Group Inc 2016-11-06 2016-11-06 /pmc/articles/PMC5099594/ /pubmed/27872830 http://dx.doi.org/10.5527/wjn.v5.i6.489 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Suzuki, Masashi
Satoh, Nobuhiko
Nakamura, Motonobu
Horita, Shoko
Seki, George
Moriya, Kyoji
Bacteremia in hemodialysis patients
title Bacteremia in hemodialysis patients
title_full Bacteremia in hemodialysis patients
title_fullStr Bacteremia in hemodialysis patients
title_full_unstemmed Bacteremia in hemodialysis patients
title_short Bacteremia in hemodialysis patients
title_sort bacteremia in hemodialysis patients
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099594/
https://www.ncbi.nlm.nih.gov/pubmed/27872830
http://dx.doi.org/10.5527/wjn.v5.i6.489
work_keys_str_mv AT suzukimasashi bacteremiainhemodialysispatients
AT satohnobuhiko bacteremiainhemodialysispatients
AT nakamuramotonobu bacteremiainhemodialysispatients
AT horitashoko bacteremiainhemodialysispatients
AT sekigeorge bacteremiainhemodialysispatients
AT moriyakyoji bacteremiainhemodialysispatients